Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-4128
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhang, Ling
dc.date.accessioned2006-08-09T11:38:32Z
dc.date.available2006-08-09T13:38:32Z
dc.date.issued2006
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/4130-
dc.description.abstractRAGE mediates diverse physiological and pathological effects by binding a variety of ligands. Despite incomplete understanding of RAGE-mediated disorders soluble RAGE (sRAGE) has been identified as a potential biomarker for RAGE-related diseases and possibly represents a hopeful pharmaceutical against RAGE-mediated disorders. Nevertheless, the source of sRAGE remains poorly investigated. Currently sRAGE is thought to be derived exclusively from alternative splicing of mRNA. In this thesis it was investigated whether sRAGE can also be released as a result of ectodomain shedding of full-length RAGE. Using cells overexpressing RAGE as a model system, it was demonstrated clearly that RAGE undergoes ectodomain shedding in both constitutive and regulated manner. Several stimuli including PMA, AMPA, calcium and chelerythrine stimulated the release of sRAGE into cell culture medium. Moreover, possible mechanisms that regulate ectodomain shedding of RAGE were investigated and it was found that shedding of RAGE is likely independent from PKC and MAPK pathways. By using gain of function and loss of function approaches MMP9 but not ADAM10, ADAM17 or MT1-MMP was characterized as the metalloproteinase that mediates shedding of RAGE. Furthermore, it was shown that cytoplasmic domain of RAGE is not essential for shedding of RAGE. In addition, the potential cleavage site of RAGE by MMP9 was investigated and a lack of sequence specificity for the RAGE processing proteinase was demonstrated by mutation analysis. Finally the physiopathological significance of shedding of RAGE is discussed. In conclusion, for the first time ectodomain shedding of human RAGE and the underlying regulatory mechanisms were investigated. The data open a new field for modulation of RAGE shedding as a novel intervention approach against RAGE-mediated diseases.en_GB
dc.language.isoeng
dc.rightsInCopyrightde_DE
dc.rights.urihttps://rightsstatements.org/vocab/InC/1.0/
dc.subject.ddc570 Biowissenschaftende_DE
dc.subject.ddc570 Life sciencesen_GB
dc.titleProteolysis of the receptor for advanced glycation end products by matrix metalloproteinasesen_GB
dc.typeDissertationde_DE
dc.identifier.urnurn:nbn:de:hebis:77-11215
dc.identifier.doihttp://doi.org/10.25358/openscience-4128-
jgu.type.dinitypedoctoralThesis
jgu.type.versionOriginal worken_GB
jgu.type.resourceText
jgu.organisation.departmentFB 10 Biologie-
jgu.organisation.year2006
jgu.organisation.number7970-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.organisation.placeMainz-
jgu.subject.ddccode570
opus.date.accessioned2006-08-09T11:38:32Z
opus.date.modified2006-08-09T11:38:32Z
opus.date.available2006-08-09T13:38:32
opus.subject.otherreceptor, shedding, MMPsen_GB
opus.organisation.stringFB 10: Biologie: FB 10: Biologiede_DE
opus.identifier.opusid1121
opus.institute.number1000
opus.metadataonlyfalse
opus.type.contenttypeDissertationde_DE
opus.type.contenttypeDissertationen_GB
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
1121.pdf1.42 MBAdobe PDFView/Open